Core Points - Chuaning Bio (301301) reported a financing net purchase of 2.73 million yuan on October 28, 2025, with a financing balance of 520 million yuan, marking a continuous net purchase of 3.81 million yuan over the last three trading days [1][2] Financing Summary - On October 28, 2025, the financing net purchase was 273.09 thousand yuan, with a financing balance of 5.20 billion yuan, representing 7.71% of the circulating market value [2] - The financing balance has shown a slight increase over the past few days, with previous net purchases of 457.3 thousand yuan on October 27 and 619.7 thousand yuan on October 24 [2] - The total financing balance as of October 28, 2025, is 5.25 billion yuan, reflecting an increase of 248.43 thousand yuan or 0.48% from the previous day [4] Margin Trading Summary - On October 28, 2025, there was a net short sale of 14.3 thousand shares, with a remaining short balance of 437.1 thousand shares [3] - The total margin trading balance, which includes both financing and short selling, is 5.25 billion yuan, indicating a 0.48% increase from the previous day [4]
川宁生物:10月28日融资净买入273.09万元,连续3日累计净买入380.79万元